BioWorld

March 10, 2003

Congress Looking Into Law Requiring Trials For Children

WASHINGTON - Companies developing biologics that could be used off-label in children may end up having to run pediatric clinical trials. (BioWorld Today) Read More

Corus Raises $40M Privately For Phase II Asthma, CF Drugs

Lymphocytes Activate Plasma Cells To Generate Huge Antibody Quantities And Multiple Myeloma

Sopherion Gets $26M In Series A To Support Platforms, Pipeline

One-Man Company, Synergia, Gets $2M To Work On Migraine

Other News To Note

Correction

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 5, 2025.

Highridge sells bone healing business to Avista

BioWorld MedTech

In the midst of June’s peak wedding season, Highridge Medical LLC called it splitsville – selling its bone healing division to Avista Healthcare Partners. The...

Pharma execs speak out: UK pricing rebates scare investors

BioWorld

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry calling up its...

DNA mutations or genetic disorder concept art

Regenxbio’s Duchenne gene therapy data positive as shares falter

BioWorld

Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...